Thomas G Beach1, Anne-Gaëlle Corbillé2,3,4,5,6, Franck Letournel5,6, Jeffrey H Kordower7, Thomas Kremer8, David G Munoz9, Anthony Intorcia1, Joseph Hentz10, Charles H Adler10, Lucia I Sue1, Jessica Walker1, Geidy Serrano1, Pascal Derkinderen2,3,4. 1. Banner Sun Health Research Institute, Sun City, AZ, USA. 2. Inserm, U913, Nantes, France. 3. Nantes University, Nantes, France. 4. Department of Neurology, CHU Nantes, Nantes, France. 5. CHU Angers, Neurobiology and Neuropathology Laboratory, Angers, France. 6. Université of Angers, UPRES EA3143, Angers, France. 7. Center for Brain Repair, Department of Pathology, Rush Medical College, Chicago, IL, USA. 8. Roche Pharmaceutical Research and Early Development, Nord DTA, Biomarker and Clinical Imaging, Roche Innovation Center, F Hoffman-La Roche, Ltd., Basel. 9. Laboratory Medicine, St. Michael's Hospital, University of Toronto & Li Ka Shing Knowledge Institute, Toronto, ON, Canada. 10. Mayo Clinic Arizona, Scottsdale, Arizona.
Abstract
BACKGROUND: Conflicting results from studies of Lewy-type α-synucleinopathy (LTS) in colonic biopsies of subjects with Parkinson's disease (PD) prompted a two-part multicenter assessment. The first assessment, now published (Acta Neuropathol Commun 4 : 35, 2016), examined archived colonic biopsies and found that none of the tested methods was adequately sensitive or specific. OBJECTIVE: As the amount of nervous tissue in typical colonic biopsies may be insufficient, and the clinical diagnosis of PD not completely accurate, the objective of the current study was to use instead full-thickness sections of sigmoid colon from autopsy-proven PD and normal subjects. METHODS: Seven different immunohistochemical (IHC) methods were used, employing five different primary antibodies and four different combinations of epitope exposure and signal development protocols. Specific staining was defined as being restricted to morphological features consistent with neuronal elements. Stained slides from each subject were independently categorized as being positive or negative for LTS, and their density semi-quantitatively graded, by four raters blinded to diagnosis. RESULTS: Agreement and mean diagnostic performance varied markedly between raters. With the two most accurate raters, 5 methods achieved diagnostic accuracies of 70% or greater; one method had 100% accuracy and 100% inter-rater agreement. The submucosa had the highest prevalence of pathological LTS staining, followed by the muscularis and mucosa. CONCLUSIONS: The major conclusion of this study is that, when sufficient submucosa and LTS is present, and when specific staining is defined as being consistent with neuronal morphology, adequately-trained raters may reliably distinguish PD colon from control using suitable IHC methods.
BACKGROUND: Conflicting results from studies of Lewy-type α-synucleinopathy (LTS) in colonic biopsies of subjects with Parkinson's disease (PD) prompted a two-part multicenter assessment. The first assessment, now published (Acta Neuropathol Commun 4 : 35, 2016), examined archived colonic biopsies and found that none of the tested methods was adequately sensitive or specific. OBJECTIVE: As the amount of nervous tissue in typical colonic biopsies may be insufficient, and the clinical diagnosis of PD not completely accurate, the objective of the current study was to use instead full-thickness sections of sigmoid colon from autopsy-proven PD and normal subjects. METHODS: Seven different immunohistochemical (IHC) methods were used, employing five different primary antibodies and four different combinations of epitope exposure and signal development protocols. Specific staining was defined as being restricted to morphological features consistent with neuronal elements. Stained slides from each subject were independently categorized as being positive or negative for LTS, and their density semi-quantitatively graded, by four raters blinded to diagnosis. RESULTS: Agreement and mean diagnostic performance varied markedly between raters. With the two most accurate raters, 5 methods achieved diagnostic accuracies of 70% or greater; one method had 100% accuracy and 100% inter-rater agreement. The submucosa had the highest prevalence of pathological LTS staining, followed by the muscularis and mucosa. CONCLUSIONS: The major conclusion of this study is that, when sufficient submucosa and LTS is present, and when specific staining is defined as being consistent with neuronal morphology, adequately-trained raters may reliably distinguish PD colon from control using suitable IHC methods.
Authors: T Lebouvier; E Coron; T Chaumette; S Paillusson; S Bruley des Varannes; M Neunlist; P Derkinderen Journal: Neurogastroenterol Motil Date: 2009-07-21 Impact factor: 3.598
Authors: Bryan A Killinger; Zachary Madaj; Jacek W Sikora; Nolwen Rey; Alec J Haas; Yamini Vepa; Daniel Lindqvist; Honglei Chen; Paul M Thomas; Patrik Brundin; Lena Brundin; Viviane Labrie Journal: Sci Transl Med Date: 2018-10-31 Impact factor: 17.956
Authors: Fredric P Manfredsson; Kelvin C Luk; Matthew J Benskey; Aysegul Gezer; Joanna Garcia; Nathan C Kuhn; Ivette M Sandoval; Joseph R Patterson; Alana O'Mara; Reid Yonkers; Jeffrey H Kordower Journal: Neurobiol Dis Date: 2018-01-16 Impact factor: 5.996
Authors: Thomas G Beach; Geidy E Serrano; Thomas Kremer; Marta Canamero; Sebastian Dziadek; Hadassah Sade; Pascal Derkinderen; Anne-Gaëlle Corbillé; Franck Letournel; David G Munoz; Charles L White; Julie Schneider; John F Crary; Lucia I Sue; Charles H Adler; Michael J Glass; Anthony J Intorcia; Jessica E Walker; Tatiana Foroud; Christopher S Coffey; Dixie Ecklund; Holly Riss; Jennifer Goßmann; Fatima König; Catherine M Kopil; Vanessa Arnedo; Lindsey Riley; Carly Linder; Kuldip D Dave; Danna Jennings; John Seibyl; Brit Mollenhauer; Lana Chahine Journal: J Neuropathol Exp Neurol Date: 2018-09-01 Impact factor: 3.685
Authors: Alcmène Chalazonitis; ZhiShan Li; Tuan D Pham; Jason Chen; Meenakshi Rao; Päivi Lindholm; Mart Saarma; Maria Lindahl; Michael D Gershon Journal: J Comp Neurol Date: 2020-03-26 Impact factor: 3.028